AOD-9604 vs BPC-157
Well Studied vs Extensively Studied
compatible Different mechanisms; sometimes combined for comprehensive healing.
Molecular Data
AOD-9604 BPC-157
Weight 1,815.1 Da 1,419.53 Da
Half-life 3-4 minutes <30 minutes
Chain 17 amino acids 15 amino acids
Type Modified hGH C-terminal fragment Pentadecapeptide
Key Benefits
AOD-9604
01 Targets fat loss through selective lipolysis
02 Avoids growth hormone side effects
03 No effect on blood glucose or insulin
04 Does not increase IGF-1 levels
05 Metabolically safer than full hGH
06 Emerging cartilage repair potential
BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
Dosing Protocols
AOD-9604
250-500mcg / Once daily
Fat loss - Standard 250-300mcg Once daily (morning, fasted)
Enhanced fat loss 400-500mcg Once daily (morning, fasted)
Joint support 250mcg Once daily
Conservative start 200mcg Once daily
BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
Side Effects
AOD-9604
Generally well-tolerated in clinical trials
Mild injection site reactions possible
No reported effects on blood glucose or insulin
BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
Contraindications
Pregnancy or breastfeeding
WADA prohibited - athletes subject to testing must avoid
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Research Evidence
AOD-9604 BPC-157
Status Well Studied Extensively Studied
References 4 studies 6 studies
Latest — January 2025
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.